Cantitate/Preț
Produs

Prostate Cancer: Translational and Emerging Therapies

Editat de Nancy A. Dawson, W. Kevin Kelly
en Limba Engleză Hardback – 4 oct 2006
Scientists have reached a critical point in the development of new therapies for prostate cancer. The information gleaned from the Human Genome Project, alongside the emergence of new technologies for the use of genetic data has expanded the physician's understanding of disease progression and widened his armamentarium for prostate cancer prevention and control. This expertly-written reference thoroughly analyzes the scientific principles and methodologies behind the most recent translational therapies and provides the necessary context, data, and studies for practitioners to select appropriate candidates for treatment and effectively apply new therapies in clinical practice.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 53558 lei  43-57 zile
  CRC Press – 5 sep 2019 53558 lei  43-57 zile
Hardback (1) 141759 lei  43-57 zile
  CRC Press – 4 oct 2006 141759 lei  43-57 zile

Preț: 141759 lei

Preț vechi: 149221 lei
-5% Nou

Puncte Express: 2126

Preț estimativ în valută:
27125 28397$ 22445£

Carte tipărită la comandă

Livrare economică 07-21 aprilie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780849371851
ISBN-10: 0849371856
Pagini: 352
Ilustrații: 25 black & white illustrations, 8 colour illustrations, 14 black & white tables, 2 black & white halftones
Dimensiuni: 152 x 229 x 24 mm
Greutate: 0.61 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press

Public țintă

Professional Reference

Cuprins

The Molecular Pathogenesis and Pathophysiology of Prostate Cancer. Targeted Therapies for Cancer: Definitions and Attributes. Novel Biomarkers for Disease Diagnosis, Prognosis, and Prediction. The Endothelin Pathway and Its Modulation in Prostate Cancer. Targeting Extracellular Molecules in Prostate Cancer-Mechanisms to Inhibit Entry into the Cell-Signaling Abyss. Immunologic Approaches to Prostate Cancer. Gene Therapy and Novel Clinical Trial Design. Angiogenesis Inhibitors in Prostate Cancer. What Antisense Oligonucleotides Have Promise in Prostate Cancer. Novel Approaches to Androgen Receptor Blockade. Can Post-Transcription Modifiers Change the Course of Prostate Cancer?. Telomere Targeting Agents. Expanding the Role of EGFR Inhibitors in Prostate Cancer. Bone-Directed Therapy in Prostate Cancer: Rationale and Novel Approaches. Inhibiting the Proteasome in Advanced Prostate Cancer. Hsp90: A Target for Prostate Cancer Therapy. Vitamin D Analogs and Their Role in Prostate Cancer. Other Novel Therapies. Molecular Imaging, Clinical Trial Design, and the Development of Emerging Therapies for Metastatic Prostate Cancer


Notă biografică

Nancy A. Dawson, W. Kevin Kelly

Descriere

Scientists have reached a critical point in the development of new therapies for prostate cancer. The information gleaned from the Human Genome Project, alongside the emergence of new technologies for the use of genetic data has expanded the physician's understanding of disease progression and widened his armamentarium for prostate cancer prevention and control. This expertly-written reference thoroughly analyzes the scientific principles and methodologies behind the most recent translational therapies and provides the necessary context, data, and studies for practitioners to select appropriate candidates for treatment and effectively apply new therapies in clinical practice.